<?xml version='1.0' encoding='utf-8'?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/buying-business-out-administration-lessons</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T08:28:49.283053Z</news:publication_date><news:title>What Buying a Business Out of Administration Really Takes</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/688c4b36-dcf1-45bd-a623-bda76b656801.jpg</image:loc><image:title>What Buying a Business Out of Administration Really Takes</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/anthropic-ipo-priced-stocks-sell-off-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T08:01:56.290256Z</news:publication_date><news:title>Anthropic IPO Prices at US$83 as Strong Stocks Sell Off on Cash Needs</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/36920dbc-8196-49ef-bce0-38bfa1352b82.jpg</image:loc><image:title>Anthropic IPO Prices at US$83 as Strong Stocks Sell Off on Cash Needs</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/agn-argenica-therapeutics-xaranetide-fda-clinical-hold-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T06:01:06.969965Z</news:publication_date><news:title>Argenica's Xaranetide Stays on FDA Hold Pending Rat Study</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/9fd4c168-f91d-4ed6-b9d3-c477e84b3901.jpg</image:loc><image:title>Argenica's Xaranetide Stays on FDA Hold Pending Rat Study</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financials/qri-qualitas-real-estate-income-fund-investor-update-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T06:00:39.237114Z</news:publication_date><news:title>Qualitas Re Income Fund Holds No Realised Losses Since Inception</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/9d99fbfe-b4bd-42fb-a8eb-0e3e1c394c4e.jpg</image:loc><image:title>Qualitas Re Income Fund Holds No Realised Losses Since Inception</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/bear-market-signals-nvidia-earnings-reaction-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T04:19:39.302008Z</news:publication_date><news:title>Why Good News Failed to Lift Nvidia and What Bear Signals Mean</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/728a2ee1-b137-420a-8cbb-07ec2855a991.jpg</image:loc><image:title>Why Good News Failed to Lift Nvidia and What Bear Signals Mean</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/eiq-echo-iq-echosolv-hf-fda-decision-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T04:10:34.136499Z</news:publication_date><news:title>Echo IQ Loses FDA Appeal Over EchoSolv HF Ruling</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/c6f7961f-b947-4f82-b0b3-a27211a7a0d3.jpg</image:loc><image:title>Echo IQ Loses FDA Appeal Over EchoSolv HF Ruling</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financials/usd-cad-forecast-20-month-high-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T04:02:14.615482Z</news:publication_date><news:title>USD/CAD Hits 20-Month High as Hawkish Fed Minutes Weigh on Loonie</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/f8f3320b-987d-409d-a549-960a5c02b077.jpg</image:loc><image:title>USD/CAD Hits 20-Month High as Hawkish Fed Minutes Weigh on Loonie</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/map-microba-life-sciences-gss-merger-bcal-support-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T03:53:03.496714Z</news:publication_date><news:title>Microba Gets Conditional Backing From Top GSS Holder BCAL</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/f0bc35f3-e134-40c8-b0ba-b29be5a938f6.jpg</image:loc><image:title>Microba Gets Conditional Backing From Top GSS Holder BCAL</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/bdx-bcal-diagnostics-gss-map-merger-position-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T03:53:03.349988Z</news:publication_date><news:title>BCAL Diagnostics Sets Terms for Backing a Revised GSS-MAP Deal</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/1751417b-ec0c-4c86-9298-5c5f15120a7f.jpg</image:loc><image:title>BCAL Diagnostics Sets Terms for Backing a Revised GSS-MAP Deal</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/cup-count-ltd-federal-court-appeal-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T03:34:37.232842Z</news:publication_date><news:title>Count Ltd Keeps Class Action Win as Full Court Dismisses Appeal</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/04c64efe-9981-40d6-af18-93d755fba0f3.jpg</image:loc><image:title>Count Ltd Keeps Class Action Win as Full Court Dismisses Appeal</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/australia-jobs-market-unemployment-october-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T03:32:06.747931Z</news:publication_date><news:title>Australia Sheds 43,500 Jobs as Unemployment Climbs to 4.9%</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/124d73ee-6b9e-42e5-9a40-90e203444d52.jpg</image:loc><image:title>Australia Sheds 43,500 Jobs as Unemployment Climbs to 4.9%</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/anthropic-ipo-trading-strategy-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T03:17:31.377735Z</news:publication_date><news:title>How to Approach the Anthropic IPO Without Chasing the Open</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/dc99e6be-2fb4-4357-9c13-36af6a94c369.jpg</image:loc><image:title>How to Approach the Anthropic IPO Without Chasing the Open</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/usd-jpy-forecast-fed-boj-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T03:03:45.300421Z</news:publication_date><news:title>USD/JPY Forecast: Why Two Hawkish Banks Have the Pair Stuck at 159</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/43bf9f35-b97c-4a81-b407-8f29caf94c37.jpg</image:loc><image:title>USD/JPY Forecast: Why Two Hawkish Banks Have the Pair Stuck at 159</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/anthropic-ipo-ant-stock-spacex-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T02:18:30.309451Z</news:publication_date><news:title>What the Anthropic IPO Means as SpaceX Shows the Risks After Debut</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/924dee82-d9a6-4c6b-87e0-dc91fee624a1.jpg</image:loc><image:title>What the Anthropic IPO Means as SpaceX Shows the Risks After Debut</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/cybersecurity-stocks-to-buy-palo-alto-guidance-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T01:17:47.486081Z</news:publication_date><news:title>Palo Alto Jumps 9.9% on Guidance Raise, but Is Rally Priced In?</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/8cad77a1-752b-49f8-8fd9-0ee510ae9ab5.jpg</image:loc><image:title>Palo Alto Jumps 9.9% on Guidance Raise, but Is Rally Priced In?</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financials/rate-hike-expectations-gold-copper-aud-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T01:17:24.171583Z</news:publication_date><news:title>How Rate Hike Expectations Hit Gold, Copper and the Aussie Dollar</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/91e3c3df-90b7-4d36-9241-f204ae1c5675.jpg</image:loc><image:title>How Rate Hike Expectations Hit Gold, Copper and the Aussie Dollar</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/jcs-jcurve-solutions-agm-fy27-guidance-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T01:09:27.099621Z</news:publication_date><news:title>Jcurve Solutions Targets 100 New Customers in Its Three Core Markets</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/bea58043-904f-4615-a366-08d8d8e9bafd.jpg</image:loc><image:title>Jcurve Solutions Targets 100 New Customers in Its Three Core Markets</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/bb1-blinklab-ltd-rd-tax-incentive-refund-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T00:25:17.486347Z</news:publication_date><news:title>BlinkLab Banks a $1.22M Tax Refund Ahead of Its FDA Submission</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/1e26049c-b3ed-48d6-b16c-d04b370c52f6.jpg</image:loc><image:title>BlinkLab Banks a $1.22M Tax Refund Ahead of Its FDA Submission</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/consumer-discretionary/ssg-shaver-shop-group-trading-update-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T23:58:42.598982Z</news:publication_date><news:title>Shaver Shop Sales Slide Eases as Early Black Friday Sales Grow</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/76ccbf78-0192-44cc-baa4-d0cb60321da8.jpg</image:loc><image:title>Shaver Shop Sales Slide Eases as Early Black Friday Sales Grow</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/cts-ceretas-cere-calm-trial-victoria-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T23:11:08.434418Z</news:publication_date><news:title>Ceretas Gains Victorian Ethics Approval for Alzheimer's Ultrasound Trial</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/7121e87b-96eb-4bce-8bdf-2fe2a4a00e63.jpg</image:loc><image:title>Ceretas Gains Victorian Ethics Approval for Alzheimer's Ultrasound Trial</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/fti-fortifai-nol8-ceo-appointment-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:54:30.131384Z</news:publication_date><news:title>FortifAI Names Revenue Chief Jason Brushe as CEO to Lead Partnerships</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/4aa7849d-0a91-45c7-bdd4-67793fffd28d.jpg</image:loc><image:title>FortifAI Names Revenue Chief Jason Brushe as CEO to Lead Partnerships</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/value-trap-stocks-memory-chip-cycle</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:49:18.876551Z</news:publication_date><news:title>Why Cheap Memory Stocks May Be Value Traps, and What to Watch</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/a2636be5-63df-433a-aec4-e28bdee420b4.jpg</image:loc><image:title>Why Cheap Memory Stocks May Be Value Traps, and What to Watch</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/ubn-urbanise-pica-group-partnership-extension-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:45:47.822126Z</news:publication_date><news:title>Urbanise Extends PICA Group Services Deal to November 2027</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/e7c8e6b1-5b89-4b0f-90dd-ae0f5efdefc3.jpg</image:loc><image:title>Urbanise Extends PICA Group Services Deal to November 2027</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/anthropic-ipo-nvidia-valuation-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:38:18.213433Z</news:publication_date><news:title>Anthropic IPO Surges While Nvidia Slides: Demand or Value?</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/c7e6756a-e2e4-4a63-bb39-4ef0061e11f2.jpg</image:loc><image:title>Anthropic IPO Surges While Nvidia Slides: Demand or Value?</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/emd-emyria-empax-therapist-recruitment-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:37:08.719236Z</news:publication_date><news:title>Emyria Recruits 31 Therapists to Lift Treatments in Existing Beds</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/6cb941b4-60c9-4afe-a810-7138e504d177.jpg</image:loc><image:title>Emyria Recruits 31 Therapists to Lift Treatments in Existing Beds</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/clg-close-the-loop-citi-refinancing-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:35:07.942011Z</news:publication_date><news:title>Close the Loop Cuts Net Debt to $16.3m in Q1 After Note Settlement</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/7a36ed13-987b-4547-b973-6c2b5322cdaa.jpg</image:loc><image:title>Close the Loop Cuts Net Debt to $16.3m in Q1 After Note Settlement</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financials/qri-qualitas-re-income-working-capital-facility-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:28:08.350882Z</news:publication_date><news:title>Qualitas Re Income Establishes $100M Bank Facility to Bridge Cash Timing</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/0d48432a-0b90-45fd-aa94-185917578843.jpg</image:loc><image:title>Qualitas Re Income Establishes $100M Bank Facility to Bridge Cash Timing</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/consumer-discretionary/sk1-skinkandy-fy27-trading-update-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:26:04.964924Z</news:publication_date><news:title>SkinKandy Lifts Revenue 21% in First 19 Weeks of FY27</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/c2f5ac02-e386-4137-8355-b1cef73452ff.jpg</image:loc><image:title>SkinKandy Lifts Revenue 21% in First 19 Weeks of FY27</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/ivx-invion-ltd-rd-tax-incentive-rebate-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:20:59.973175Z</news:publication_date><news:title>Invion Banks a $502,675 Tax Refund That Needs No New Shares</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/c33e73a8-6edb-4937-a001-ad43313a562c.jpg</image:loc><image:title>Invion Banks a $502,675 Tax Refund That Needs No New Shares</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/ldx-lumos-diagnostics-febridx-portugal-expansion-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:13:55.629345Z</news:publication_date><news:title>Lumos Diagnostics Adds Portugal to FebriDx Map With a Stocking Order</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/d6de6092-dee8-49e0-a5b4-5326ba3f8657.jpg</image:loc><image:title>Lumos Diagnostics Adds Portugal to FebriDx Map With a Stocking Order</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/dvl-dorsavi-french-distribution-agreement-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:09:40.556677Z</news:publication_date><news:title>dorsaVi Signs First French Distributor in Capital-Light Expansion</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/61457183-f943-46d2-b2e5-bf7931a8d926.jpg</image:loc><image:title>dorsaVi Signs First French Distributor in Capital-Light Expansion</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/cvb-curvebeam-ai-hirise-china-order-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T22:09:16.419272Z</news:publication_date><news:title>CurveBeam AI Lands Its First China Order, Four HiRise Scanners</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/170c29bc-c0d2-453e-bea7-07a88805a64b.jpg</image:loc><image:title>CurveBeam AI Lands Its First China Order, Four HiRise Scanners</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/par-paradigm-biopharmaceuticals-ipps-row-trial-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:56:56.300770Z</news:publication_date><news:title>Paradigm Analysis Points to Possible Trial Outside US for iPPS</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/51699c90-18ac-49e8-8102-f9ad084af044.jpg</image:loc><image:title>Paradigm Analysis Points to Possible Trial Outside US for iPPS</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/iod-iodm-uk-education-cash-receipts-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:55:21.261117Z</news:publication_date><news:title>IODM Hits Second Straight A$350K Month of UK Cash Receipts</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/a83faea1-99bb-4fbc-ad8b-ecec2e28e1ec.jpg</image:loc><image:title>IODM Hits Second Straight A$350K Month of UK Cash Receipts</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/cu6-clarity-pharmaceuticals-amplify-trial-follow-up-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:49:59.199149Z</news:publication_date><news:title>Clarity Finishes Prostate Cancer Trial Follow-Ups, Data Due Early 2027</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/af23ba22-d636-45f4-822c-70e854fdb827.jpg</image:loc><image:title>Clarity Finishes Prostate Cancer Trial Follow-Ups, Data Due Early 2027</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/axe-archer-materials-biosensor-beta-prototype-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:49:15.028519Z</news:publication_date><news:title>Archer Materials Finishes Blood Sensor Beta Ready for External Testing</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/b8033d0b-4a74-46fe-b1f9-fdcbe43d6c6d.jpg</image:loc><image:title>Archer Materials Finishes Blood Sensor Beta Ready for External Testing</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/tcl-transurban-october-2026-traffic-update</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:48:50.019866Z</news:publication_date><news:title>Transurban Traffic Edges Up 0.7% in October as Rain Hits Brisbane</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/1a2a8b71-d131-455f-891b-936a18d5a74a.jpg</image:loc><image:title>Transurban Traffic Edges Up 0.7% in October as Rain Hits Brisbane</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/acw-actinogen-xanamem-alzheimers-trial-results-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:48:17.471425Z</news:publication_date><news:title>Actinogen Xanamem Misses Main Goal, Older Subgroup Trends to 30% Slowing</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/76a10b20-6a78-44f5-bd26-4129690575b8.jpg</image:loc><image:title>Actinogen Xanamem Misses Main Goal, Older Subgroup Trends to 30% Slowing</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/c79-chrysos-corporation-photonassay-trading-update-november-2026-az71r</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:45:53.160304Z</news:publication_date><news:title>Chrysos Lifts Four-Month Revenue 27% as Sample Volumes Jump 43%</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/f4e0c9b8-92eb-4474-a797-0a960e37d50b.jpg</image:loc><image:title>Chrysos Lifts Four-Month Revenue 27% as Sample Volumes Jump 43%</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/c79-chrysos-corporation-photonassay-trading-update-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:44:34.539038Z</news:publication_date><news:title>Chrysos Revenue Climbs 27% to $36.7m in Unaudited Start to FY27</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/d2c8c2ae-4861-4188-99ad-2fecb3f732d8.jpg</image:loc><image:title>Chrysos Revenue Climbs 27% to $36.7m in Unaudited Start to FY27</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/atx-amplia-therapeutics-accent-mini-trial-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:42:57.304445Z</news:publication_date><news:title>Amplia Clears Ethics Hurdle and Readies Its Pancreatic Cancer Trial</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/f1a727d1-8dad-4aab-a13f-9c3846c82fba.jpg</image:loc><image:title>Amplia Clears Ethics Hurdle and Readies Its Pancreatic Cancer Trial</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/ehl-emeco-holdings-fy27-trading-update-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:40:58.334838Z</news:publication_date><news:title>Emeco Guides FY27 Operating EBITDA of $275M to $285M, Weighted to H2</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/9de57cf5-5cf9-4e54-9e90-db24ea0c1d15.jpg</image:loc><image:title>Emeco Guides FY27 Operating EBITDA of $275M to $285M, Weighted to H2</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/consumer-staples/aac-australian-agricultural-company-hy27-results-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:34:29.265891Z</news:publication_date><news:title>AACo Lifts Record First-Half Operating Profit to $64.8m, Up 63%</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/c4806c17-b3aa-4265-a69a-eea6f62517dd.jpg</image:loc><image:title>AACo Lifts Record First-Half Operating Profit to $64.8m, Up 63%</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financials/cgf-challenger-ltd-tal-daiichi-takeover-offer-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:33:41.855726Z</news:publication_date><news:title>Challenger Rebuffs TAL Daiichi's $12.20 Revised Offer as Too Low</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/5dd4d7c2-97ba-463f-8b0e-6c708a830282.jpg</image:loc><image:title>Challenger Rebuffs TAL Daiichi's $12.20 Revised Offer as Too Low</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/usd-twd-forecast-33-00-capital-flows-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:33:01.662774Z</news:publication_date><news:title>USD/TWD Slips From 33.00, but Capital Flows Keep Pressure On</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/f16dd803-ba10-4c97-92c4-e67fecddf465.jpg</image:loc><image:title>USD/TWD Slips From 33.00, but Capital Flows Keep Pressure On</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/imm-immutep-eftisarc-neo-sarcoma-trial-results-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:33:01.381405Z</news:publication_date><news:title>Immutep's Sarcoma Combo Keeps 81% of Patients Disease Free at 12 Months</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/cc6f97ef-89c9-4713-ab5a-a831d4a66483.jpg</image:loc><image:title>Immutep's Sarcoma Combo Keeps 81% of Patients Disease Free at 12 Months</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/singapore-nodx-record-usd-sgd-flat-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T21:00:54.715213Z</news:publication_date><news:title>Singapore NODX Hits Record 79.8%, So Why Is the Currency Flat?</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/0214f5d8-a758-48fb-a9e2-257e15e9c318.jpg</image:loc><image:title>Singapore NODX Hits Record 79.8%, So Why Is the Currency Flat?</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/oca-oceania-healthcare-1h27-interim-result-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T20:47:31.800067Z</news:publication_date><news:title>Oceania Healthcare Lifts First-Half Earnings 18% to a Record $49.0m</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/e4f5eef0-9bea-4e4e-9590-b31bd863a9d0.jpg</image:loc><image:title>Oceania Healthcare Lifts First-Half Earnings 18% to a Record $49.0m</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/consumer-staples/a2m-the-a2-milk-company-china-imf-recovery-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T20:47:13.109920Z</news:publication_date><news:title>a2 Milk Estimates China Formula Offtake at 50% of Pre-Disruption Levels</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/9d1af514-da99-4eb9-aba1-88b909a77683.jpg</image:loc><image:title>a2 Milk Estimates China Formula Offtake at 50% of Pre-Disruption Levels</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/consumer-discretionary/bgp-briscoe-group-ceo-andrew-scott-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T20:47:03.983555Z</news:publication_date><news:title>Briscoe Group Names Andrew Scott CEO as Rod Duke Plans Transition</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/6c7ccb3d-d53b-4325-b123-a8edf1effdbf.jpg</image:loc><image:title>Briscoe Group Names Andrew Scott CEO as Rod Duke Plans Transition</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-markets/rupiah-record-low-bank-indonesia-rate-hike-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T20:32:29.771675Z</news:publication_date><news:title>Bank Indonesia Hikes to 6.00% but Rupiah Stays Near Record Low</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/9c1545c3-27c3-4b89-8c30-f2f12450d2ca.jpg</image:loc><image:title>Bank Indonesia Hikes to 6.00% but Rupiah Stays Near Record Low</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/hungary-forint-outlook-mnb-rate-cut-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T12:03:43.417961Z</news:publication_date><news:title>Hungary Forint Outlook: Rate Cut Talk Tests the Carry Case</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/0ae8412b-f0e0-4c01-8e44-7c51715cd3d4.jpg</image:loc><image:title>Hungary Forint Outlook: Rate Cut Talk Tests the Carry Case</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/indian-rupee-rebound-usd-inr-outlook-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T11:33:31.770409Z</news:publication_date><news:title>What Is Really Driving the Indian Rupee Rebound, and Will It Last?</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/8205ea19-e975-4999-96ec-0c6e2651e5af.jpg</image:loc><image:title>What Is Really Driving the Indian Rupee Rebound, and Will It Last?</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financials/us-fiscal-deficit-treasury-yields-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T10:19:31.690248Z</news:publication_date><news:title>Why a 6% US Fiscal Deficit at Full Employment Worries Bond Markets</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/4766123f-9ed9-48f1-990e-0f5298b0ad3e.jpg</image:loc><image:title>Why a 6% US Fiscal Deficit at Full Employment Worries Bond Markets</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/eur-usd-outlook-commerzbank-rebound-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T10:00:39.072061Z</news:publication_date><news:title>EUR/USD Outlook: Why Commerzbank Sees a Brief Rebound Near 1.10</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/d21c2542-00f2-4b30-912c-7deac4cb700b.jpg</image:loc><image:title>EUR/USD Outlook: Why Commerzbank Sees a Brief Rebound Near 1.10</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/consumer-discretionary/ctt-cettire-ytd-fy27-trading-update-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T08:44:39.997123Z</news:publication_date><news:title>Cettire Lifts Gross Revenue 18% as Non-US Sales Jump 36%</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/bda8d19a-518a-4063-a704-f822319de9d5.jpg</image:loc><image:title>Cettire Lifts Gross Revenue 18% as Non-US Sales Jump 36%</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/epx-ltd-capital-raising-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T08:40:44.034818Z</news:publication_date><news:title>EPX Launches Up to $1.7M Raise to Fund Customer Installations</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/2afb6d1b-1834-4b59-8792-679618ce3b41.jpg</image:loc><image:title>EPX Launches Up to $1.7M Raise to Fund Customer Installations</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/eml-payments-fy27-guidance-affirmed-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T08:27:48.003508Z</news:publication_date><news:title>EML Payments Eyes FY27 EBITDA of $50m to $54m as Renewals Hold</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/cdd2fceb-b67b-4588-87d3-323e8c34c7c3.jpg</image:loc><image:title>EML Payments Eyes FY27 EBITDA of $50m to $54m as Renewals Hold</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/map-microba-life-sciences-genetic-signatures-merger-termination-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T08:13:38.668018Z</news:publication_date><news:title>Microba Merger Off as Genetic Signatures Walks Away</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/02cb4b6c-b0ba-41f9-a8ad-b51ff61d1707.jpg</image:loc><image:title>Microba Merger Off as Genetic Signatures Walks Away</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/mem-memphasys-felix-monash-ivf-rollout-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T07:57:43.173526Z</news:publication_date><news:title>Memphasys Gets Monash IVF Go-Ahead to Roll Felix Out Nationwide</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/a70739d1-8f3e-439b-a41f-aff1c7b08828.jpg</image:loc><image:title>Memphasys Gets Monash IVF Go-Ahead to Roll Felix Out Nationwide</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/kno-knosys-libero-us-market-entry-rights-issue-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T07:42:14.414034Z</news:publication_date><news:title>Knosys Launches Up to $4.3m Rights Issue to Fund US Library Push</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/da386508-676b-4089-87db-587f523c03ee.jpg</image:loc><image:title>Knosys Launches Up to $4.3m Rights Issue to Fund US Library Push</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/communication-services/frx-flexiroam-quarterly-reporting-relief-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T07:41:24.727438Z</news:publication_date><news:title>FlexiRoam Drops Quarterly Reports After Five Cash-Positive Quarters</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/7d0a3036-bf44-4e56-b97a-16787fc7a9bd.jpg</image:loc><image:title>FlexiRoam Drops Quarterly Reports After Five Cash-Positive Quarters</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/imm-immutep-efti-root-cause-analysis-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T07:28:33.775280Z</news:publication_date><news:title>Immutep Narrows Efti Focus to Head and Neck and Sarcoma Cancers</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/bcc2ba36-8d71-4d93-859f-e0349499c800.jpg</image:loc><image:title>Immutep Narrows Efti Focus to Head and Neck and Sarcoma Cancers</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/cancer-trial-results-explained-amplia-accent</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T06:15:31.329665Z</news:publication_date><news:title>How to Read Cancer Trial Results: Amplia's ACCENT Data Explained</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/892bb6da-aab0-4b54-ad8d-df7a5b116ecf.jpg</image:loc><image:title>How to Read Cancer Trial Results: Amplia's ACCENT Data Explained</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/tea-tasmea-ltd-fy27-guidance-upgrade-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T04:27:55.097854Z</news:publication_date><news:title>Tasmea Lifts FY27 Profit Guidance Again After a Record First Quarter</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/4d9621d6-efcf-45c4-aeac-606f4ea26642.jpg</image:loc><image:title>Tasmea Lifts FY27 Profit Guidance Again After a Record First Quarter</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/anthropic-ipo-float-day-one-trading-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T04:18:29.262927Z</news:publication_date><news:title>What the Anthropic IPO Float Really Means for Day-One Trading</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/4dcfca41-41aa-4f4d-92ad-0730d5cc3950.jpg</image:loc><image:title>What the Anthropic IPO Float Really Means for Day-One Trading</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/nvidia-earnings-tech-selloff-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T04:17:50.407845Z</news:publication_date><news:title>Why Tech Sold Off Before Nvidia Earnings and What It Signalled</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/f637fdf5-897f-4f0a-a271-70df36f7c5bf.jpg</image:loc><image:title>Why Tech Sold Off Before Nvidia Earnings and What It Signalled</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/aud-usd-forecast-rba-rate-hike-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T03:35:46.923104Z</news:publication_date><news:title>AUD/USD Forecast: Why the Aussie Fell Despite an RBA Rate Hike</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/3e0d0301-6427-4c91-b8c6-79c069170ddd.jpg</image:loc><image:title>AUD/USD Forecast: Why the Aussie Fell Despite an RBA Rate Hike</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/dtz-dotz-nano-revised-placement-terms-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T03:07:20.959873Z</news:publication_date><news:title>Dotz Nano Loses Its CEO and Reprices Its $2M Raise 32% Lower</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/fb5e8f06-de7b-4776-93da-d4506d71a6a7.jpg</image:loc><image:title>Dotz Nano Loses Its CEO and Reprices Its $2M Raise 32% Lower</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financials/nzd-usd-forecast-kiwi-fomc-minutes-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T03:01:45.190607Z</news:publication_date><news:title>NZD/USD Forecast: Kiwi Stuck Below 0.5500 Ahead of Fed Minutes</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/5370e6ff-ce07-4051-adf6-9fdcafd9c38a.jpg</image:loc><image:title>NZD/USD Forecast: Kiwi Stuck Below 0.5500 Ahead of Fed Minutes</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/map-microba-life-sciences-gss-merger-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T02:25:20.069399Z</news:publication_date><news:title>Microba Scraps Genetic Signatures Merger After Funding Shortfall</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/09abb572-bea6-40fa-b2df-a26af9eb9ed3.jpg</image:loc><image:title>Microba Scraps Genetic Signatures Merger After Funding Shortfall</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/consumer-staples/yow-yowie-group-placement-yow-brands-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T01:58:40.083017Z</news:publication_date><news:title>Yowie Targets A$2.5M Placement Ahead of Proposed ASX Reinstatement</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/0fab72bf-bb56-4e29-9d00-e18e4df820bb.jpg</image:loc><image:title>Yowie Targets A$2.5M Placement Ahead of Proposed ASX Reinstatement</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/nvidia-earnings-reaction-stock-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T01:46:09.753312Z</news:publication_date><news:title>Nvidia Beats Estimates, but Stock Gains Just 2.6% in a Weak Market</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/7bbeeeb7-93f2-4fbc-aebd-fa89cef904be.jpg</image:loc><image:title>Nvidia Beats Estimates, but Stock Gains Just 2.6% in a Weak Market</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/consumer-discretionary/sfc-schaffer-corporation-south-connect-jandakot-agm-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T01:45:05.633145Z</news:publication_date><news:title>Schaffer Lays Out Jandakot Growth Plan After Lifting Equity Value 6%</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/cea78f2f-8fd5-4b96-a3ab-9e8c110368a6.jpg</image:loc><image:title>Schaffer Lays Out Jandakot Growth Plan After Lifting Equity Value 6%</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/investing-after-bad-year-topaz-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T01:33:28.226038Z</news:publication_date><news:title>Why Investing After a Bad Year Has Paid Off for Topaz Holders</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/8a2e292f-4d1b-486a-bbbb-793e9e057b9b.jpg</image:loc><image:title>Why Investing After a Bad Year Has Paid Off for Topaz Holders</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/buying-business-out-of-administration</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T01:25:32.220353Z</news:publication_date><news:title>Buying a Business Out of Administration: Bargain or Warning Sign?</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/d93b38e0-9349-42ad-8353-cc3f3e520e9d.jpg</image:loc><image:title>Buying a Business Out of Administration: Bargain or Warning Sign?</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/bls-pharmaceuticals-uk-manufacturing-facility-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T22:20:45.783742Z</news:publication_date><news:title>BLS Pharmaceuticals Faces Home Office Inspection Before UK Licence</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/87120b51-69cf-40cb-9a09-2dbf1eaf9416.jpg</image:loc><image:title>BLS Pharmaceuticals Faces Home Office Inspection Before UK Licence</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/rac-racura-oncology-emili-aml-trial-ethics-approval-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T22:07:08.706176Z</news:publication_date><news:title>Racura Oncology Gains Ethics Approval for Its EMILI AML Trial in Israel</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/3fa8e3ed-c8be-4fa1-a7c7-b79867a5d240.jpg</image:loc><image:title>Racura Oncology Gains Ethics Approval for Its EMILI AML Trial in Israel</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/nxl-nuix-haveli-acquisition-proposal-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T22:05:10.311444Z</news:publication_date><news:title>Nuix Gives Haveli Five Weeks to Firm Up a Non-Binding $2.75 Bid</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/c4d07c18-324e-44da-a01b-70ace734a24b.jpg</image:loc><image:title>Nuix Gives Haveli Five Weeks to Firm Up a Non-Binding $2.75 Bid</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/ect-environmental-clean-technologies-mxene-reactor-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:59:42.375946Z</news:publication_date><news:title>Environmental Clean Technologies Fires Up Its Texas MXene Reactor</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/de37839c-2ee6-4201-afef-8b738ab309a8.jpg</image:loc><image:title>Environmental Clean Technologies Fires Up Its Texas MXene Reactor</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/xrg-xreality-group-causeway-funding-increase-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:55:05.022094Z</news:publication_date><news:title>xReality Group Adds $1M Funding Cushion to Chase Bigger Orders</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/cc46c842-c34c-41c7-8535-6a8b64124eca.jpg</image:loc><image:title>xReality Group Adds $1M Funding Cushion to Chase Bigger Orders</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/emv-emvision-medical-devices-emu-regional-benefits-study-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:53:25.917528Z</news:publication_date><news:title>EMVision Banks $306,750 More Grant Cash for Its Rural Stroke Scanner</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/da652bf3-c999-44d6-b338-c82598566944.jpg</image:loc><image:title>EMVision Banks $306,750 More Grant Cash for Its Rural Stroke Scanner</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/pps-praemium-appoints-denis-orrock-ceo-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:50:18.132431Z</news:publication_date><news:title>Praemium Names Denis Orrock Permanent CEO After Acting Stint</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/a115305b-7d57-4d67-92a2-c4a09448ff25.jpg</image:loc><image:title>Praemium Names Denis Orrock Permanent CEO After Acting Stint</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/aqn-biodegradable-collar-keeper-tbs-supply-deal</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:50:08.707303Z</news:publication_date><news:title>Aquirian's TBS Accepts First Collar Keeper, Worth $1.05M if Volumes Hold</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/00cbb3a3-d3f9-4a0b-b279-7558f5896ab9.jpg</image:loc><image:title>Aquirian's TBS Accepts First Collar Keeper, Worth $1.05M if Volumes Hold</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/aqn-aquirian-biodegradable-collar-keeper-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:46:39.751476Z</news:publication_date><news:title>Aquirian Readies First Biodegradable Collar Keeper for December Launch</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/881a6827-5e39-44dd-8b69-93b3634a44fb.jpg</image:loc><image:title>Aquirian Readies First Biodegradable Collar Keeper for December Launch</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/pxa-pexa-group-ipart-final-report-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:41:26.116331Z</news:publication_date><news:title>PEXA Faces Possible $50M Revenue Hit From IPART's Fee Cut</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/686ab9e2-9a87-413f-b5fa-fdc9082fde9a.jpg</image:loc><image:title>PEXA Faces Possible $50M Revenue Hit From IPART's Fee Cut</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/nvu-nanoveu-ecs-studio-development-suite-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:36:14.823458Z</news:publication_date><news:title>Nanoveu Lets Chip Customers Convert and Test Their Own AI Models</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/6cf20872-1a8e-4f2d-9b9f-aea4369cdd5f.jpg</image:loc><image:title>Nanoveu Lets Chip Customers Convert and Test Their Own AI Models</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/materials/ect-commissions-mxene-reactor-gator-point-program-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:33:34.800873Z</news:publication_date><news:title>Environmental Clean Technologies Funds MXene Test Run at Metallium Lab</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/1f3db76e-a92f-4fa2-9a7c-f1af2c664667.jpg</image:loc><image:title>Environmental Clean Technologies Funds MXene Test Run at Metallium Lab</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/healthcare/xen-xenitra-jd-health-agreement-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:33:12.381542Z</news:publication_date><news:title>Xenitra Eyes A$100m of JD Health Sales, but the Target Is Non-Binding</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/510b1017-a548-4c0e-98e1-7851589ed44d.jpg</image:loc><image:title>Xenitra Eyes A$100m of JD Health Sales, but the Target Is Non-Binding</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/sector-rotation-ai-diversification-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T21:04:07.083934Z</news:publication_date><news:title>Sector Rotation 2026: Is Your AI Diversification Really One Bet?</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/82a9a88a-aab5-4277-b3a1-69b6c250700a.jpg</image:loc><image:title>Sector Rotation 2026: Is Your AI Diversification Really One Bet?</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/industrials/ift-infratil-independent-valuation-update-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T20:48:15.019182Z</news:publication_date><news:title>Infratil Longroad Stake Falls NZ$38.9m on Higher Discount Rates</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/1f46990b-1f4d-47ce-bf8f-4f4123031d91.jpg</image:loc><image:title>Infratil Longroad Stake Falls NZ$38.9m on Higher Discount Rates</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/morningstar-star-rating-microsoft-explained</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T20:33:54.270920Z</news:publication_date><news:title>Why Microsoft Earns Only 3 Morningstar Stars Despite Strong Returns</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/3e79e01d-7b4a-4f12-8b21-e8b2bf50f1ba.jpg</image:loc><image:title>Why Microsoft Earns Only 3 Morningstar Stars Despite Strong Returns</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/technology/semiconductor-rebound-bear-market-rally-soxx-nvidia-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T19:52:51.779448Z</news:publication_date><news:title>Chip Rebound or Bear Market Rally? What SOXX and Nvidia Options Say</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/353bf84b-9ae3-477f-8c3b-379d9b1ed251.jpg</image:loc><image:title>Chip Rebound or Bear Market Rally? What SOXX and Nvidia Options Say</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/china-fx-intervention-reserves-state-banks-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T19:33:48.577111Z</news:publication_date><news:title>Why China's FX Reserves Barely Moved as Banks Bought US$65B</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/5424d575-3947-49bc-b81a-6f126c68b7ba.jpg</image:loc><image:title>Why China's FX Reserves Barely Moved as Banks Bought US$65B</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/dollar-index-outlook-dxy-rally-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T19:04:27.394864Z</news:publication_date><news:title>Dollar Index Outlook: Why Strong Data Failed to Hold the Rally</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/f589aeb2-466d-4c03-a851-e793f77c3127.jpg</image:loc><image:title>Dollar Index Outlook: Why Strong Data Failed to Hold the Rally</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/head-and-shoulders-pattern-bitcoin-biotech-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T17:48:21.629789Z</news:publication_date><news:title>What the Head and Shoulders Pattern Says About Biotech and Bitcoin</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/f2be20dc-3d6e-42f9-804f-48bb97ab1dfb.jpg</image:loc><image:title>What the Head and Shoulders Pattern Says About Biotech and Bitcoin</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/eur-usd-forecast-euro-sliding-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T16:34:12.912795Z</news:publication_date><news:title>EUR/USD Forecast: Why the Euro Is Sliding Despite Cheaper Oil</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/fc00bc98-af28-4e57-85fb-7db2c5b8fc2b.jpg</image:loc><image:title>EUR/USD Forecast: Why the Euro Is Sliding Despite Cheaper Oil</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/us-dollar-outlook-fed-hike-bets-oil-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T16:00:54.189721Z</news:publication_date><news:title>US Dollar Outlook: Why Fed Hike Bets Are Beating Cheaper Oil</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/06415f21-3543-4139-9f48-11e7490420e0.jpg</image:loc><image:title>US Dollar Outlook: Why Fed Hike Bets Are Beating Cheaper Oil</image:title></image:image></url><url><loc>http://bedrock.stockwirex.com/asx-stock-news/financial-services/zew-sentiment-eur-usd-november-2026</loc><news:news><news:publication><news:name>Aigentic</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T11:05:30.458921Z</news:publication_date><news:title>ZEW Sentiment Jumps to 35.6, but the Euro Barely Moves</news:title></news:news><image:image><image:loc>https://media.stockwirex.com/articles/media/featured_image/be3388d4-1807-4f85-b54c-15cfcae3f523.jpg</image:loc><image:title>ZEW Sentiment Jumps to 35.6, but the Euro Barely Moves</image:title></image:image></url></urlset>